There have been 50 recent insider transactions recorded for Pieris Pharmaceuticals, Inc. (PIRS), including 42 buys and 5 sells. Total insider buying was valued at $12.03M and total insider selling at $2.66M.
Notable insiders with recent activity include Geraghty James A, Kiritsy Christopher P, Dellora Investments Lp. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — PIRS
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2024-12-12 |
Geraghty James A |
Director |
Return of Shares |
1 |
$0.01 |
$0.01 |
- |
| 2024-12-02 |
Kiritsy Christopher P |
Director |
RSU Award |
500 |
$16.43 |
$8.22K |
500 |
| 2024-11-06 |
Dellora Investments Lp |
10 Percent Owner |
Unknown |
- |
- |
- |
141,079 |
| 2024-08-12 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Informative Buy |
757 |
$15.88 |
$12.02K |
15,067 |
| 2024-08-09 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Informative Buy |
3,000 |
$14.89 |
$44.68K |
127,331 |
| 2024-08-07 |
Geraghty James A |
Director |
Informative Buy |
1 |
$1.00 |
$1.00 |
1 |
| 2024-07-24 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Unknown |
- |
- |
- |
14,310 |
| 2023-06-21 |
Geraghty James A |
Director |
RSU Award |
45,000 |
$0.26 |
$11.7K |
45,000 |
| 2023-06-21 |
Kiritsy Christopher P |
Director |
RSU Award |
40,000 |
$0.26 |
$10.4K |
40,000 |
| 2023-06-21 |
Sherman Matthew L |
Director |
RSU Award |
40,000 |
$0.26 |
$10.4K |
40,000 |
| 2023-06-21 |
Kiener Peter A |
Director |
RSU Award |
40,000 |
$0.26 |
$10.4K |
40,000 |
| 2023-06-21 |
Richman Michael |
Director |
RSU Award |
40,000 |
$0.26 |
$10.4K |
40,000 |
| 2023-06-21 |
Barbier Ann |
Director |
RSU Award |
40,000 |
$0.26 |
$10.4K |
40,000 |
| 2023-06-21 |
Said Maya R. |
Director |
RSU Award |
40,000 |
$0.26 |
$10.4K |
40,000 |
| 2023-05-25 |
Kiritsy Christopher P |
Director |
Informative Buy |
10,000 |
$0.85 |
$8.5K |
20,000 |
| 2023-05-11 |
Bvf Partners L P/il |
10 Percent Owner |
Disposition |
265,000 |
$7.10 |
$1.88M |
- |
| 2023-02-24 |
Yoder Stephen S. |
Chief Executive Officer |
RSU Award |
634,021 |
$1.39 |
$881.29K |
634,021 |
| 2023-02-24 |
Bures Thomas |
Chief Financial Officer |
RSU Award |
249,080 |
$1.39 |
$346.22K |
249,080 |
| 2023-02-24 |
Kaufmann Hitto |
Chief Scientific Officer |
RSU Award |
249,080 |
$1.39 |
$346.22K |
249,080 |
| 2023-02-24 |
Olwill Shane |
Chief Development Officer |
RSU Award |
249,080 |
$1.39 |
$346.22K |
249,080 |
| 2023-02-24 |
Mousa Ahmed |
Chief Business Officer |
RSU Award |
249,080 |
$1.39 |
$346.22K |
249,080 |
| 2022-06-22 |
Geraghty James A |
Director |
RSU Award |
45,000 |
- |
- |
45,000 |
| 2022-06-22 |
Kiritsy Christopher P |
Director |
RSU Award |
40,000 |
$1.82 |
$72.8K |
40,000 |
| 2022-06-22 |
Sherman Matthew L |
Director |
RSU Award |
40,000 |
- |
- |
40,000 |
| 2022-06-22 |
Kiener Peter A |
Director |
RSU Award |
40,000 |
- |
- |
40,000 |
| 2022-06-22 |
Richman Michael |
Director |
RSU Award |
40,000 |
- |
- |
40,000 |
| 2022-06-22 |
Barbier Ann |
Director |
RSU Award |
40,000 |
$1.82 |
$72.8K |
40,000 |
| 2022-06-22 |
Said Maya R. |
Director |
RSU Award |
40,000 |
- |
- |
40,000 |
| 2022-05-13 |
Demuth Tim |
Chief Medical Officer |
Informative Buy |
6,000 |
$1.71 |
$10.26K |
6,000 |
| 2022-02-22 |
Yoder Stephen S. |
Chief Executive Officer |
RSU Award |
625,874 |
$3.03 |
$1.9M |
625,874 |
| 2022-02-22 |
Bures Thomas |
Chief Financial Officer |
RSU Award |
215,819 |
$3.03 |
$653.93K |
215,819 |
| 2022-02-22 |
Kaufmann Hitto |
SVP, Chief Scientific Officer |
RSU Award |
215,819 |
$3.03 |
$653.93K |
215,819 |
| 2022-02-22 |
Demuth Tim |
Chief Medical Officer |
RSU Award |
100,000 |
$3.03 |
$303K |
100,000 |
| 2022-02-22 |
Olwill Shane |
Chief Development Officer |
RSU Award |
215,819 |
$3.03 |
$653.93K |
215,819 |
| 2022-02-22 |
Mousa Ahmed |
Chief Business Officer |
RSU Award |
215,819 |
$3.03 |
$653.93K |
215,819 |
| 2021-10-06 |
Mousa Ahmed |
Chief Business Officer |
Disposition |
150,000 |
$2.50 |
$375K |
- |
| 2021-08-30 |
Olwill Shane |
Chief Development Officer |
Informative Sell |
29,200 |
$5.15 |
$150.38K |
4,638 |
| 2021-08-01 |
Demuth Tim |
Officer |
Unknown |
- |
- |
- |
- |
| 2021-08-01 |
Demuth Tim |
Chief Medical Officer |
RSU Award |
360,000 |
$3.48 |
$1.25M |
360,000 |
| 2021-08-01 |
Olwill Shane |
Chief Development Officer |
Disposition |
82,000 |
$3.09 |
$253.38K |
- |
| 2021-06-25 |
Geraghty James A |
Director |
RSU Award |
45,000 |
$4.00 |
$180K |
45,000 |
| 2021-06-25 |
Kiritsy Christopher P |
Director |
RSU Award |
40,000 |
$4.00 |
$160K |
40,000 |
| 2021-06-25 |
Sherman Matthew L |
Director |
RSU Award |
40,000 |
$4.00 |
$160K |
40,000 |
| 2021-06-25 |
Kiener Peter A |
Director |
RSU Award |
40,000 |
$4.00 |
$160K |
40,000 |
| 2021-06-25 |
Richman Michael |
Director |
RSU Award |
40,000 |
$4.00 |
$160K |
40,000 |
| 2021-06-25 |
Barbier Ann |
Director |
RSU Award |
40,000 |
$4.00 |
$160K |
40,000 |
| 2021-06-25 |
Said Maya R. |
Director |
RSU Award |
40,000 |
$4.00 |
$160K |
40,000 |
| 2021-03-04 |
Yoder Stephen S. |
Chief Executive Officer |
RSU Award |
530,000 |
$2.50 |
$1.33M |
530,000 |
| 2021-03-04 |
Bures Thomas |
Vice President, Finance |
RSU Award |
150,000 |
$2.50 |
$375K |
150,000 |
| 2021-03-04 |
Kaufmann Hitto |
SVP, Chief Scientific Officer |
RSU Award |
220,000 |
$2.50 |
$550K |
220,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
